v3.25.4
Shareholders' Deficit - Narrative (Details) - USD ($)
12 Months Ended
Jan. 03, 2026
Dec. 28, 2024
Dec. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercised (in shares) 0 0  
Granted (in shares) 0    
Approved share repurchase program $ 600,000,000    
Remaining authorized stock purchase plan $ 348,000,000    
Stock Award      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 1,500,000 1,200,000 1,300,000
Antidilutive securities excluded from calculation of earnings per share (in shares) 300,000 100,000 100,000
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense related to non-vested awards $ 300,000    
Weighted average period to recognize remaining expense over 6 months    
Time- Based Stock Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense related to non-vested awards $ 6,800,000    
Weighted average period to recognize remaining expense over 1 year 9 months 18 days    
Performance- Based Stock Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense related to non-vested awards $ 3,700,000    
Weighted average period to recognize remaining expense over 2 years 1 month 6 days